AAAAAA
Results: 1-25/45
Authors:
CHURCHILL DR
PYM AS
BABIKER AG
BACK DJ
WEBER JN
Citation: Dr. Churchill et al., HYPERLIPIDEMIA FOLLOWING TREATMENT WITH PROTEASE INHIBITORS IN PATIENTS WITH HIV-I INFECTION, British journal of clinical pharmacology, 46(5), 1998, pp. 518-519
Authors:
BARRY MG
MERRY C
LLOYD J
HALIFAX K
CAREY P
MULCAHY F
BACK DJ
Citation: Mg. Barry et al., VARIABILITY IN TROUGH PLASMA SAQUINAVIR CONCENTRATIONS IN HIV PATIENTS - A CASE FOR THERAPEUTIC DRUG-MONITORING, British journal of clinical pharmacology, 45(5), 1998, pp. 501-502
Authors:
BARRY M
MULCAHY F
BACK DJ
Citation: M. Barry et al., ANTIRETROVIRAL THERAPY FOR PATIENTS WITH HIV DISEASE, British journal of clinical pharmacology, 45(3), 1998, pp. 221-228
Authors:
EAGLING VA
TJIA JF
BACK DJ
Citation: Va. Eagling et al., DIFFERENTIAL SELECTIVITY OF CYTOCHROME-P450 INHIBITORS AGAINST PROBE SUBSTRATES IN HUMAN AND RAT-LIVER MICROSOMES, British journal of clinical pharmacology, 45(2), 1998, pp. 107-114
Authors:
HOGGARD PG
MANION V
BARRY MG
BACK DJ
Citation: Pg. Hoggard et al., EFFECT OF PROTEASE INHIBITORS ON NUCLEOSIDE ANALOG PHOSPHORYLATION IN-VITRO, British journal of clinical pharmacology, 45(2), 1998, pp. 164-167
Authors:
MERRY C
BARRY MG
MULCAHY F
TJIA JF
HALIFAX KL
HEAVEY J
KELLY C
BACK DJ
Citation: C. Merry et al., RITONAVIR PHARMACOKINETICS ALONE AND IN COMBINATION WITH SAQUINAVIR IN HIV-INFECTED PATIENTS, AIDS, 12(3), 1998, pp. 325-327
Authors:
MERRY C
BARRY MG
MULCAHY F
RYAN M
TJIA JF
HALIFAX KL
BRECKENRIDGE AM
BACK DJ
Citation: C. Merry et al., THE PHARMACOKINETICS OF COMBINATION THERAPY WITH NELFINAVIR PLUS NEVIRAPINE, AIDS, 12(10), 1998, pp. 1163-1167
Authors:
TOMLINSON ES
MAGGS JL
PARK BK
BACK DJ
Citation: Es. Tomlinson et al., DEXAMETHASONE METABOLISM IN-VITRO - SPECIES-DIFFERENCES, Journal of steroid biochemistry and molecular biology, 62(4), 1997, pp. 345-352
Authors:
VEAL GJ
BARRY MG
KHOO SH
BACK DJ
Citation: Gj. Veal et al., IN-VITRO SCREENING OF NUCLEOSIDE ANALOG COMBINATIONS FOR POTENTIAL USE IN ANTI-HIV THERAPY, AIDS research and human retroviruses, 13(6), 1997, pp. 481-484
Authors:
EAGLING VA
BACK DJ
BARRY MG
Citation: Va. Eagling et al., DIFFERENTIAL INHIBITION OF CYTOCHROME-P450 ISOFORMS BY THE PROTEASE INHIBITORS, RITONAVIR, SAQUINAVIR AND INDINAVIR, British journal of clinical pharmacology, 44(2), 1997, pp. 190-194
Authors:
BACK DJ
MCINNES GT
TUCKER GT
Citation: Dj. Back et al., NEW COVER - RENEWED COMMITMENT, British journal of clinical pharmacology, 43(1), 1997, pp. 1-2
Authors:
MERRY C
BARRY MG
MULCAHY F
RYAN M
HEAVEY J
TJIA JF
GIBBONS SE
BRECKENRIDGE AM
BACK DJ
Citation: C. Merry et al., SAQUINAVIR PHARMACOKINETICS ALONE AND IN COMBINATION WITH RITONAVIR IN HIV-INFECTED PATIENTS, AIDS, 11(4), 1997, pp. 29-33
Authors:
MERRY C
BARRY MG
MULCAHY F
HALIFAX KL
BACK DJ
Citation: C. Merry et al., SAQUINAVIR PHARMACOKINETICS ALONE AND IN COMBINATION WITH NELFINAVIR IN HIV-INFECTED PATIENTS, AIDS, 11(15), 1997, pp. 117-120
Authors:
HOGGARD PG
KEWN S
BARRY MG
KHOO SH
BACK DJ
Citation: Pg. Hoggard et al., EFFECTS OF DRUGS ON 2',3'-DIDEOXY-2',3'-DIDEHYDROTHYMIDINE PHOSPHORYLATION IN-VITRO, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1231-1236
Authors:
KEWN S
VEAL GJ
HOGGARD PG
BARRY MG
BACK DJ
Citation: S. Kewn et al., LAMIVUDINE (3TC) PHOSPHORYLATION AND DRUG-INTERACTIONS IN-VITRO, Biochemical pharmacology, 54(5), 1997, pp. 589-595
Authors:
TOMLINSON ES
LEWIS DFV
MAGGS JL
KROEMER HK
PARK BK
BACK DJ
Citation: Es. Tomlinson et al., IN-VITRO METABOLISM OF DEXAMETHASONE (DEX) IN HUMAN LIVER AND KIDNEY - THE INVOLVEMENT OF CYP3A4 AND CYP17 (17,20 LYASE) AND MOLECULAR MODELING STUDIES, Biochemical pharmacology, 54(5), 1997, pp. 605-611
Authors:
SALES SD
VEAL GJ
HART CA
BACK DJ
Citation: Sd. Sales et al., ZIDOVUDINE (ZDV) CYTOTOXICITY IN-VITRO LINKED TO INTRACELLULAR ZDV-MONOPHOSPHATE CONCENTRATIONS, British journal of clinical pharmacology, 42(5), 1996, pp. 671-672
Authors:
VEAL GJ
BARRY MG
KHOO SH
BACK DJ
Citation: Gj. Veal et al., ACTIVATION OF NUCLEOSIDE ANALOG DRUGS USED IN COMBINATION IN THE MRC QUATTRO TRIAL, British journal of clinical pharmacology, 42(5), 1996, pp. 672-673
Authors:
EAGLING VA
TJIA JF
BACK DJ
Citation: Va. Eagling et al., DIFFERENTIAL SELECTIVITY OF CYTOCHROME-P450 INHIBITORS AGAINST 4 PROBE SUBSTRATES IN HUMAN AND RAT-LIVER MICROSOMES, British journal of clinical pharmacology, 42(5), 1996, pp. 673-673
Authors:
VEAL GJ
HOGGARD PG
BARRY MG
KHOO S
BACK DJ
Citation: Gj. Veal et al., INTERACTION BETWEEN LAMIVUDINE (3TC) AND OTHER NUCLEOSIDE ANALOGS FORINTRACELLULAR PHOSPHORYLATION, AIDS, 10(5), 1996, pp. 546-548
Authors:
BARRY MG
KHOO SH
VEAL GJ
HOGGARD PG
GIBBONS SE
WILKINS EGL
WILLIAMS O
BRECKENRIDGE AM
BACK DJ
Citation: Mg. Barry et al., THE EFFECT OF ZIDOVUDINE DOSE ON THE FORMATION OF INTRACELLULAR PHOSPHORYLATED METABOLITES, AIDS, 10(12), 1996, pp. 1361-1367
Authors:
PIRMOHAMED M
WILD MJ
KITTERINGHAM NR
OBRIEN K
BUCHAN IE
BACK DJ
PARK BK
Citation: M. Pirmohamed et al., LACK OF ASSOCIATION BETWEEN SCHIZOPHRENIA AND THE CYP2D6 GENE POLYMORPHISMS, American journal of medical genetics, 67(2), 1996, pp. 236-237
Authors:
GENTILE DM
TOMLINSON ES
MAGGS JL
PARK BK
BACK DJ
Citation: Dm. Gentile et al., DEXAMETHASONE METABOLISM BY HUMAN LIVER IN-VITRO - METABOLITE IDENTIFICATION AND INHIBITION OF 6-HYDROXYLATION, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 105-112
Authors:
TJIA JF
COLBERT J
BACK DJ
Citation: Jf. Tjia et al., THEOPHYLLINE METABOLISM IN HUMAN LIVER-MICROSOMES - INHIBITION STUDIES, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 912-917
Authors:
VEAL GJ
BARRY MG
BACK DJ
Citation: Gj. Veal et al., ZALCITABINE (DDC) PHOSPHORYLATION AND DRUG-INTERACTIONS, Antiviral chemistry & chemotherapy, 6(6), 1995, pp. 379-384